Production Operator

Interim report Quarter 3, 2026. Stable volumes, resilient profitability and strong cash flow Quarter 3, 2026 * Net sales increased 4.1% to SEK 36,060m (34,638) * Organic sales growth amounted to -0.3%, of which volume accounted for -0.1% and price/mix -0.2%. * EBITA amounted to SEK 3,636m (5,152) * EBITA excl. IAC amounted to SEK 4,725m (5,056) * The EBITA margin excl. IAC amounted to 13.1% (14.6) * ROCE amounted to 11.9% (17.9) and ROCE excl. IAC was 15.5% (17.6) * Profit for the period was SEK 2,346m (3,358) * Earnings per share was SEK 3.47 (4.86) * Operating cash flow amounted to SEK 5,783m (5,324) * Essity has entered into an agreement to acquire Kenvue's feminine care business in Brazil. The completion of the transaction is expected to close during the second quarter of 2027. CEO'S COMMENTS Essity's development in the third quarter was characterized by stability and resilience in a challenging market. Profitability remained good despite intensifying cost headwinds, and cash flow was strong. Volumes were stable, and Essity strengthened its market positions in several strategic segments, demonstrating the competitiveness of its business. At the same time, the Group's sales development was not at the level Essity is aiming for, and Essity continue its efforts to accelerate profitable growth and offset higher costs through price increases and efficiency improvements. Cost savings were delivered according to plan, investments in marketing and customer offerings are yielding results, and sales prices were higher than in the second quarter of this year. Health & Medical delivered organic growth and good profitability during the quarter. Incontinence Products continued to grow, and the sales development in Medical Solutions was positive, with good growth in wound care. Sales in Personal Care also performed well, supported by continued high growth and increased market shares in Incontinence Products and Feminine Care. Consumer Tissue had lower sales due to lower volumes, primarily driven by optimization of the production footprint in Latin America, and price reductions in previous quarters. In Professional Hygiene, profitability remained solid, although volume development was not satisfactory. The decline was concentrated to the base assortment and smaller distributors which were more affected by the weaker market. However, Essity continued to grow in strategic products and increased sales to its larger distributors and customers. Product launches and price increases During the quarter, Essity launched new and improved products across several categories to further strengthen its offering. For example, Essity expanded its range of compression garments with JOBST(R) Elvarex(R) Soft ready-to-wear, allowing Essity to reach patients more quickly. Essity continued to actively work on price increases to offset higher costs, and all business areas reported higher sales prices compared with the second quarter. "Our focus is on translating strong market positions into profitable growth" Another acquisition in feminine care During the quarter, Essity took another step forward in its strategy to grow in attractive, value-creating categories by entering into an agreement to acquire Kenvue's feminine care business in Brazil. The acquisition includes the market-leading brands Carefree, Sempre Livre and o.b., and strengthens Essity's position in feminine care in Latin America. Brazil represents a significant growth opportunity in hygiene and health, where Essity already hold a leading position in incontinence products with TENA. This acquisition follows its previous feminine care acquisition in North America and represents another concrete step in the expansion of its feminine care business, where Essity has a proven track record of success and see good potential for profitable growth. The transaction is subject to regulatory approval and is expected to close in the second quarter of 2027. Strategic review of Consumer Tissue The strategic review of Consumer Tissue is proceeding according to plan. Essity has assessed the conditions for a separation and are now ready to move forward with evaluating the value creation potential of the different strategic alternatives - a separation or Consumer Tissue remaining part of Essity. The ambition is to identify the alternative that provides the best opportunity for both Consumer Tissue and Essity to reach their full potential and maximize long-term value creation. Focus on higher growth Its focus is on translating strong market positions into profitable growth. Essity continue to prioritize investments where Essity see the greatest opportunities to grow and create value, while improving efficiency and addressing increasing cost headwinds through pricing and cost measures. In parallel, Essity continue to develop its portfolio. Essity has clear priorities and will now ensure that its initiatives have a greater impact on the Group's growth and profitability. Ulrika Kolsrud, President and CEO Invitation to presentation President and CEO Ulrika Kolsrud and Executive Vice President and CFO Fredrik Rystedt will present the report at a live webcast and teleconference at 09:00 a.m. CEST on October 22, 2026. Link to the live presentation, which can also be viewed afterwards: https://essity.videosync.fi/2026-10-22 Contact information for conference call with the possibility to ask questions: UK: +44 (0) 33 0551 02 00 USA: +1 786 697 35 01 SWE: +46 (0) 8 505 204 24 Please call in well in advance of the start of the presentation. Indicate: "Essity". For additional information Fredrik Rystedt, Executive Vice President and CFO, tel: +46 (0) 8 788 51 31 Sandra Åberg, Vice President Investor Relations, tel: +46 (0) 70 564 96 89 Per Lorentz, Vice President Corporate Affairs, tel: +46 (0) 73 313 30 55 NB: This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. This report has been prepared in both Swedish and English versions. In case of variations in the content between the two versions, the Swedish version shall govern. The information was submitted for publication, through the agency of Karl Stoltz, Public Relations Director, at 07:00 CET on October 22, 2026. This report has not been reviewed by the company's auditors.

Lawsuit accuses Essity, Edgewell, J&J of violating PFAS ban in California. By Sara Samora | Manufacturing Drive | October 20, 2026 Read the full article by Sara Samora (Manufacturing Drive) "The lawsuit cited an independent lab test conducted in 2024 that found one or more of Carefree's five product layers contained PFOA, and allegedly continued to incorporate the toxic substances since then. Law firm Custodio and Dubey initially pointed to the independent lab test and sent a 60-day notice in February 2024 to the California attorney general and every district and city attorney with a population greater than 750,000 in the state, informing them of their findings as reason to prosecute Edgewell. Custodio and Dubey sued Edgewell in September 2024, but requested a dismissal the following year, Bloomberg Law reported."

Stockholm market ended the week with broad gains, OMXS30 index rose 1.3 percent. Published on 10/16/2026 at 11:38 am EDT Finwire - Translated by Marketscreener - See original The Stockholm market rose in broad-based gains on Friday. The increase was in line with Frankfurt, while London and Paris posted more moderate gains. Among the companies reporting today were Investor and Avanza. At the close, the OMXS30 index was up 1.25 percent at 3,296.84. Shares worth approximately SEK 28.6bn changed hands on the Stockholm market. Among the market's larger industrial sectors, financials posted the strongest performance, rising 1.6 percent. At the other end of the scale, health care was at the bottom, down 0.5 percent. Among the leading stocks included in the OMXS30 index, EQT rose 3.3 percent, while Saab B gained 2.9 percent. AstraZeneca posted the weakest performance, down 1.9 percent, while ABB fell 0.6 percent. Investment company Investor's adjusted net asset value was SEK 411 per share on September 30, an increase of 4 percent during the quarter. Investor is also buying shares in private equity firm EQT from Wallenberg Investments for SEK 3.5bn. The stock rose 2.3 percent. Online broker Avanza Bank reported operating profit that was slightly below expectations in the third quarter, while the company lowered its cost forecast for its expansion into Denmark. Revenue was also slightly below consensus. The stock dropped 2.8 percent. Mining company Lundin Mining expects positive price adjustments of $51m before tax in the third quarter, primarily related to previous copper sales. At the same time, the company reported costs of $66m following winter storms that temporarily disrupted operations at the Caserones mine in Chile. The company also expects realized losses of $9m from gold derivatives. In addition, Lundin Mining received $23m in additional consideration from the sale of Neves-Corvo to Boliden. The stock rose 2.9 percent. Hygiene and health care company Essity rose 0.6 percent. Asia Pulp & Paper and private equity firm CVC Capital Partners are considering separate bids for Essity's consumer tissue business. RGE is also among the potential bidders, Bloomberg News reported, citing sources. Essity began a strategic review of the business area in May. European defense stocks had a strong trading day on Friday, and Sweden's Saab joined its sector peers in rising. Nuclear technology company Studsvik signed a framework agreement with Norway's NND for the management of spent nuclear fuel from the research reactors in Halden and Kjeller. The agreement runs until 2055 and has an estimated minimum value of SEK 875m, while the total value is estimated at SEK 3bn-4bn. The stock advanced 4.6 percent. Lighting company Plejd delivered a strong third-quarter report. Revenue rose 31 percent and operating profit increased 60 percent from the same quarter last year. Value growth in installations amounted to 26 percent globally. The stock rose 2.5 percent. Real estate company Platzer's net property management income increased 10 percent to SEK 218m in the third quarter. The stock fell 1.0 percent. Real estate company NP3's net property management income amounted to SEK 355m in the third quarter, an increase of 12 percent. NP3 reiterated its forecast for net property management income of SEK 1.24bn for the full year 2026. The stock rose 2.7 percent. Automaker Volvo Cars expanded its collaboration with technology company Nvidia to develop safer automated driving for future vehicle models. The stock rose 2.8 percent. A few recommendation changes appeared in the news flow. It was a double upgrade for major bank Nordea, which was raised to Accumulate from Reduce by Inderes and to Buy from Hold by Arctic Securities. The stock closed 0.3 percent higher. Danske Bank dropped its Buy recommendation for Ericsson and lowered its rating to Hold. The stock nevertheless rose 1.9 percent. Wallenstam climbed 2.7 percent after Kepler Cheuvreux raised its recommendation to Buy from Hold. Bjorn Borg rose 1.3 percent. Inderes raised its recommendation to Buy from Accumulate. (C) Finwire - 2026